0001104659-26-052426
SEC filingEvotec SE nominates Dr. Wolfgang Hofmann as independent Supervisory Board member and enters cooperation agreement with MAK Capital, with AGM vote on June 11, 2026.
Evotec SE announced the nomination of Dr. Wolfgang Hofmann for election as an independent member of the Supervisory Board at the upcoming Annual General Meeting on June 11, 2026. The AGM agenda also includes the previously announced nomination of Dieter Weinand as Chairman of the Supervisory Board and a proposal to increase the board size from six to seven members. Concurrently, Evotec entered into a cooperation agreement with MAK Capital Fund LP, a key shareholder, under which MAK Capital agreed to customary voting and cooperation commitments. This agreement follows constructive discussions and reflects Evotec's commitment to open shareholder dialogue. The appointments aim to strengthen oversight and governance capabilities, supporting the company's transformation plans to grow shareholder value. The cooperation agreement is expected to foster continued collaboration between the Supervisory Board, Management Board, and MAK Capital.